Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that it has triggered the first $20 million contingent payment under its previously disclosed strategic ...

Shares of Agenus climbed after the clinical-stage immuno-oncology company triggered the first $20 million contingent payment under its strategic collaboration with Zydus Lifesciences. The stock jumped ...

Zydus Lifesciences will roll out generic semaglutide injections in India post-patent expiry, using a reusable single-pen ...

Zydus to launch Semaglutide Injection in India, featuring a unique reusable pen for improved diabetes and obesity management.

Celebrating the indomitable spirit of women this International Women's Day, Zydus Pinkathon Delhi brought together nearly 6,000 women at the iconic Jawaharlal Nehru Stadium for its landmark eighth ...

The 2026 Indian Coast Guard 10K Run in Noida and the Zydus Pinkathon in Delhi highlighted community participation in ...

Ivermectin tablets are prescription anti-parasitic medications primarily indicated for treating parasitic worm infections.

Celebrating the indomitable spirit of women this International Women’s Day, Zydus Pinkathon Delhi brought together nearly ...

Zydus Lifesciences Limited, ("Zydus"), an innovation-led life-sciences company with an international presence with ...

Zydus Lifesciences receives USFDA approval to market generic Ivermectin & Dapsone tablets. Anti-parasitic & leprosy ...

A proposed biosimilar to immuno-oncology therapy Keytruda? Zydus Lifesciences announced that the pivotal Dahlia pharmacokinetic study (PK study) has successfully met its primary study objective. The ...

(Fixes formatting in the last bullet) Feb 25 - Zydus Lifesciences will launch generic versions of semaglutide injections for obesity and diabetes in India after patent expiry of the Ozempic active ...